Teladoc Health, Inc.

TDOC Healthcare Health Information Services

Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024. In the quarter to June 2026, revenue fell 3.95%, EPS fell 10.5%, free cash flow fell 27.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

5.67 0.30 −5.03%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
−7.7×
Dividend yield
—
F-score
5/9
Altman Z
−6.66
Beneish M
−3.26
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.62 0.39 0.49 0.54
P/FCF ratio
17.33 7.71 8.98 12.63
P/Operating CF
23.74 102.59 14.06 13.78
P/B ratio
1.17 0.73 0.89 0.98
EV/Sales
1.11 0.70 0.79 0.86
EV/EBITDA
13.51 9.38 10.79 13.21
EV/FCF
31.09 13.99 14.55 20.18
Current Ratio
0.83 2.80 2.77 2.70
Net Debt/EBITDA
4.02 7.56 3.38 5.07
Debt/Equity
0.76 0.75 0.72 0.71
Earnings Yield
(11.67%) (17.80%) (16.29%) (16.56%)
Free Cash Flow Yield
5.77% 12.98% 11.13% 7.92%
Free Cash Flow per Share
0.13 (0.15) 0.30 0.38
Book value per Share
7.24 7.46 7.86 7.87
Free Cash Flow
23.07 (26.31) 53.42 67.95
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates